British Nursing News Get 25% off the Oxford Handbook for Nursing Series - Go to the Just for Nurses website now!
  WWW.BNN-ONLINE.CO.UK     Saturday, 20 April 2024 
Search stories for:
Sample search for:

Thursday, 18 May 2006 12:01
BNN: British Nursing News Online · www.bnn-online.co.uk
New antibiotic could fight superbugs
Scientists have discovered a new antibiotic which is effective in fighting drug-resistant hospital superbugs.

Platensimycin is in the early stages of development but could potentially prove invaluable in the fight against bacteria such as methicillin-resistant Staphylococcus aureus (MRSA) and Enterococcus, resistant to even the most powerful modern antibiotics such as vancomycin.

Most antibiotics were discovered in the 1940s and 50s and work by disrupting the formation of a bacterium’s walls, proteins or DNA, so that it cannot reproduce and spread.

But DNA mutations can make bacteria immune to the effects of drugs and, as the use of antibiotics has risen in the past few decades, so has the number of pathogenic bacteria that have developed resistance to them.

"It is believed that the widespread drug resistance among bacterial pathogens is due to the limited choice of antibiotics," wrote Eric Brown of McMaster University in Canada in an accompanying article.

The new antibiotic, a molecule produced by Streptomyces platensis, a fungus-like bacterium, works in a different way to previous antibiotics, inhibiting an enzyme called FabF which is used in the formation of fatty acids in bacterial cells.

Dr Brown said platensimycinhad an “extraordinary” way of working, although it is not the first anti-bacterial compound to attack the formation of fatty acids.

An experiment on mice infected with Staphylococcus aureus showed that the new drug cleared the bacteria with no harmful side effects. Despite this, it will be at least ten years before it becomes available in pharmacies.

"The path ahead remains a long one that includes further preclinical study and, if these studies are successful, extensive clinical trials for safety and efficacy in humans," said Dr Brown. "Platensimycin is nevertheless the most potent inhibitor reported so far for FabF."


Sponsored by The Nursing Portal
Add your own comments on this story - currently inactive due to spamming
Your name
(Optional):
Your email address
(Optional):
Your comments:
back to previous page

Home   Top   Disclaimer    Site Credits

Nursing Jobs | Just for Nurses | Nursing Agencies List | Charles Bloe Training
Nursing Portal | Nursing Events | Brutish Nursing | British Nursing Websites
Website Development and SEO Services

 

KEY WORKERS ARE PRICED OUT OF HOMES
DIET 'AFFECTS ARTERIES OF FOETUS'
BOOST FOR CERVICAL CANCER
ONE IN 20 VIOLENT CRIMES COMMITTED BY MENTALLY ILL
FISH OIL 'AIDS WEIGHT LOSS' WITHOUT DIET
STAFFS MAY STRIKE OVER HEAT
BEAT A FAG WITH A JAG
ALCOHOL KILLS RECORD NUMBER OF WOMEN IN SCOTLAND
FORMER PRESIDENT URGES GMC REMODELLING
DARK SKIN 'DOES NOT BLOCK CANCER'
Nurses Reconnected
   UK Nursing. Copyright, Design and Content, © 1999 - 2024. All rights reserved  
Click here if you need to advertise to nurses